ADB-BUTINACA acts as an agonist at CB1 and CB2 receptors, mimicking the consequences of organic cannabinoids. It is usually used in investigation to check receptor interactions as well as their impact on the central nervous program.This compound is meant exclusively for laboratory and forensic investigation and is not accredited for human or veteri